Breast Cancer. Malignant neoplasm of breast
Conditions
Interventions
Intervention 1: Intervention group:For the intervention group, during chemotherapy, a one-time Shiatso massage will be performed on the Hugo spots for 5 minutes and 2 minutes of rest for up to 20 minu
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Cancer patients who have been undergoing chemotherapy for at least one period. Age more than 18 and less than 60 years. Diagnosis of stages 2, 3 and 4 of cancer According to the relevant physician. Cancer patients with 6 months of diagnosis Full of consciousness No history of mental illness, seizures or epilepsy, asthma, thyroid disorder, olfactory disorder, severe heart failure that has been approved by a doctor No history of smoking and drug addiction Under chemotherapy with a special protocol
Exclusion criteria
Exclusion criteria: Paralysis of the hands
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anxiety. Timepoint: Measure the amount of anxiety before each chemotherapy treatment with the intervention and immediately after each chemotherapy treatment with the intervention. Method of measurement: Spielberger Questionnaire.;Pain. Timepoint: Measure the amount of pain before each chemotherapy treatment with the intervention and immediately after each chemotherapy treatment with the intervention. Method of measurement: Visual analog scale.;Blood pressure. Timepoint: Measure the amount of blood pressure before each chemotherapy treatment with the intervention and immediately after each chemotherapy treatment with the intervention. Method of measurement: Mercury blood pressure device.;Number of heartbeats. Timepoint: Measure the amount of number of heartbeats before each chemotherapy treatment with the intervention and immediately after each chemotherapy treatment with the intervention. Method of measurement: Cardiac and pulmonary monitor device.;Number of breaths. Timepoint: Measure the amount of number of breaths before each chemotherapy treatment with the intervention and immediately after each chemotherapy treatment with the intervention. Method of measurement: Cardiac and pulmonary monitor device. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZohreh Farahani
Arak University of Medical Sciences
Outcome results
None listed